Injective

Blockchain technology for Decentralized Finance & Web3 Innovation

San Francisco, United States · Founded 2018 · $203.0M raised

Headquarters
San Francisco
Employees
51–200
Founded
2018
Business Model
platform
Total Funding
$203.0M
Last Round
$40.0M Venture RoundMar 2026
Rounds
4

About

Injective is a high-performance Layer 1 blockchain purpose-built for decentralized finance and Web3 financial applications, founded by Eric Chen and Albert Chon in 2018 through Binance Labs' first incubation program. The protocol provides out-of-the-box modules for building sophisticated DeFi apps including derivatives, cross-chain margin trading, synthetic assets, and futures markets. Based in New York City, Injective Labs has raised over $57M from investors including Binance, Pantera Capital, Jump, and Brevan Howard.

Summary

Injective is a Fintech company based in San Francisco, United States, founded in 2018. It has raised $203.0M in total across 4 rounds, most recently a $40.0M Venture Round round in Mar 2026. Investors include Jump Crypto.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Venture RoundFunding RoundMar 2026
$40.0M

Sign up to see all 4 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies